ICICI Lombard registers PAT growth of 20.2% in Q2 FY2025 at ₹ 6.94 billion

ICICI Lombard registers PAT growth of 20.2% in Q2 FY2025 at ₹ 6.94 billion

 

·       Gross Direct Premium Income (GDPI) of the Company stood at ₹ 144.09 billion in H1 FY2025 compared to ₹ 124.72 billion in H1 FY2024, a growth of 15.5%, which was higher than the industry growth of 7.0%. Excluding crop and mass health, GDPI growth of the Company was at 15.0%, which was higher than the industry growth of 10.9% in H1 FY2025.

 

o   GDPI of the Company was at ₹ 67.21 billion in Q2 FY2025 as against ₹ 60.86 billion in Q2 FY2024, growth of 10.4%. This growth was higher than industry growth of 2.0%. Excluding crop and mass health, GDPI growth of the Company was at 9.4%, which was higher than the industry growth of 6.9% in Q2 FY2025.

 

·       Combined ratio stood at 103.2% for H1 FY2025 compared to 103.8% for H1 FY2024. Excluding the impact of CAT losses of ₹ 0.94 billion in H1 FY2025 and ₹ 0.83 billion in H1 FY2024, the combined ratio was 102.2% and 102.7% respectively.

o   Combined ratio stood at 104.5% in Q2 FY2025 as against 103.9% in Q2 FY2024. Excluding the impact of CAT losses of ₹ 0.94 billion in Q2 FY2025 and ₹ 0.48 billion in Q2 FY2024, the combined ratio was 102.6% and 102.8% respectively.

 

·       Profit before tax (PBT) grew by 31.9% to ₹ 16.93 billion in H1 FY2025 as against ₹ 12.84 billion in H1 FY2024 whereas PBT grew by 20.3% to ₹ 9.19 billion in Q2 FY2025 as against ₹ 7.64 billion in Q2 FY2024.

o   Capital gains were at ₹ 5.21 billion in H1 FY2025 as against ₹ 2.87 billion in H1 FY2024. Capital gains were at ₹ 2.37 billion in Q2 FY2025 as against ₹ 1.65 billion in Q2 FY2024.

 

 

·       Consequently, Profit after tax (PAT) grew by 31.7% to ₹ 12.74 billion in H1 FY2025 as against ₹ 9.68 billion in H1 FY2024. PAT grew by 20.2% to ₹ 6.94 billion in Q2 FY2025 from ₹ 5.77 billion in Q2 FY2024.

·       Return on Average Equity (ROAE) was 20.3% in H1 FY2025 compared to 18.0% in H1 FY2024 while ROAE was 21.8% in Q2 FY2025 compared to 21.1% in Q2 FY2024.

 

·       Solvency ratio was 2.65x as at September 30, 2024 as against 2.56x as at June 30, 2024 and higher than the minimum regulatory requirement of 1.50x. Solvency ratio was 2.62x as at March 31, 2024.

 

·       The Board of Directors of the company has declared an interim dividend of ₹ 5.50 per share for H1 FY2025 as against ₹ 5.00 for H1 FY2024.

Share:

No comments:

Post a Comment

Popular Posts

Blog Archive

Recent Posts

Featured Post

Paying premium regularly for Health Insurance Policy. Do I have any concessions in making a claim?

Paying premium regularly for Health Insurance Policy. Do I have any concessions in making a claim?   Q and A I have taken a med...